Grant & Eisenhofer P.A.

Grant & Eisenhofer is one of the most successful plaintiff advocacy firms in the country. With extensive trial skills, G&E has successfully litigated numerous individual claims in state, federal and appellate courts. Our experienced attorneys are investigating vision loss claims due to Elmiron. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.

Elmiron Litigation Bellwether Trials May Occur in January 2023

With over 200 cases filed against Janssen Pharmaceuticals concerning vision-related problems linked to Elmiron, plaintiffs are seeing new developments towards trial, possibly in 2023. Plaintiffs allege long-term use of the bladder-pain drug caused vision impairment symptoms, and for many, a degenerative eye disorder called “pigmentary maculopathy.” The cases were consolidated into a multi-district litigation in …. Read More

Comments Off on Elmiron Litigation Bellwether Trials May Occur in January 2023

More Women File Claims Against Elmiron Manufacturer for Vision Loss

Women across the country are filing lawsuits against Janssen Pharmaceuticals, manufacturer of the drug Elmiron, claiming the drug caused their vision problems such as maculopathy. Long-term use of the drug, which is prescribed to treat bladder pain, has been linked to vision problems such as blurry vision, loss of close vision, night blindness, and other …. Read More

Comments Off on More Women File Claims Against Elmiron Manufacturer for Vision Loss

Elmiron MDL Leadership Established, Including G&E’s Sindhu Daniel 

G&E principal Sindhu Daniel was selected to serve on the Plaintiffs Steering Committee in the Elmiron Multidistrict Litigation (MDL). The leadership team includes mostly female attorneys and is a highly diverse group. Approximately 130 Elmiron lawsuits were centralized in December 2020 before The Honorable Brian R. Martinotti in New Jersey to expedite pretrial proceedings. As …. Read More

Comments Off on Elmiron MDL Leadership Established, Including G&E’s Sindhu Daniel 

Elmiron and Macular Degeneration

The link between Elmiron and vision damage has come to the forefront of recent news—as well as the courtroom. Many patients experiencing vision loss symptoms are looking for answers to questions such as: does Elmiron cause macular degeneration? Our law firm is investigating vision loss claims nationwide due to Elmiron. Learn more about Elmiron, vision …. Read More

Comments Off on Elmiron and Macular Degeneration

Multi-District Litigation Status Granted in Elmiron Litigation

In the latest news in the Elmiron litigation, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has approved all Elmiron lawsuits to be consolidated in the District of New Jersey before Brian R. Martinotti. This tactic, called a multi-district litigation, or MDL, consolidates cases that allege similar claims to expedite pretrial proceedings and eliminate duplicative …. Read More

Comments Off on Multi-District Litigation Status Granted in Elmiron Litigation

Case Report Suggests Elmiron May Effect Vision Years Post-Treatment  

As patients that took Elmiron continue to file lawsuits concerning its vision-loss side-effects, a new case report indicates some alarming findings. In the report, published in Retinal Cases & Brief Reports, doctors from Emory University School of Medicine describe a woman who experienced vision problems three years after stopping Elmiron. The 44-year old developed Elmiron-induced …. Read More

Comments Off on Case Report Suggests Elmiron May Effect Vision Years Post-Treatment  

Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

As litigation against Janssen Pharmaceuticals, manufacturer of bladder pain drug Elmiron, mounts, the FDA has approved a change in the drug’s labeling in the U.S. The label of the drug’s “Warnings” section previously did not list any risks concerning visual impairment; however, labeling must now contain “Retinal Pigmentary Changes.” These changes may manifest as pigmentary …. Read More

Comments Off on Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use

In one of the first cases concerning eye damage related to drug Elmiron, the complaint filed in New Jersey Superior Court alleges failure to warn of the drug’s side effects. Elmiron is a prescription drug widely used to treat a bladder pain condition known as interstitial cystitis. Concerns relating to potentially permanent vision loss and …. Read More

Comments Off on Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use